The University of Southampton
University of Southampton Institutional Repository

Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions

Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions
Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions
It is well known that aspirin consumption temporarily reduces overall otoacoustic emission (OAE) amplitude in humans. However, little is known about changes in the separate components of distortion product otoacoustic emissions (DPOAE), which may be distinguished by examining phase gradients. The effects of aspirin on the phase gradient of the DPOAE 2F1–F2 obtained with fixed frequency ratio sweeps were studied longitudinally in a group of twelve subjects in whom a temporary hearing loss was induced by aspirin consumption. DPOAE were recorded daily for two days pre-aspirin consumption, during the three days of aspirin consumption and two days afterwards. DP-grams were recorded over a restricted frequency range centered on 2, 3, 4 and 6 kHz with the following stimulus levels: L1/L2 of 60/50–80/70 in 10-dB steps.
The effects of aspirin on the phase gradients varied between the subjects and across frequency: the general trend was that the phase gradient became steeper across successive sessions for the higher frequencies, while no significant effect was found at the lower frequencies.
These results suggest that aspirin may have more persistent effects on cochlear function than are disclosed by measurements of hearing threshold level or DPOAE amplitude. Particularly, DPOAE phase gradient appears to be increased by aspirin consumption and has not recovered two days after cessation of aspirin intake, despite almost complete recovery of DPOAE amplitude and hearing threshold levels. These findings may suggest differential effects on the distortion and reflection mechanisms considered to underlie DPOAE generation.
distortion product otoacoustic emissions, aspirin, phase gradient
0378-5955
44-52
Parazzini, M.
45948c82-e33a-40df-a266-a614691f0434
Hall, A.J.
37be6558-de66-4f11-96e1-70067b684f57
Lutman, M.E.
765efa2b-f995-4ab4-b9bf-acbb6bb6f890
Kapadia, S.
65ad07a7-5df0-4cce-8bbc-68524a732590
Parazzini, M.
45948c82-e33a-40df-a266-a614691f0434
Hall, A.J.
37be6558-de66-4f11-96e1-70067b684f57
Lutman, M.E.
765efa2b-f995-4ab4-b9bf-acbb6bb6f890
Kapadia, S.
65ad07a7-5df0-4cce-8bbc-68524a732590

Parazzini, M., Hall, A.J., Lutman, M.E. and Kapadia, S. (2005) Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions. Hearing Research, 205 (1-2), 44-52. (doi:10.1016/j.heares.2005.02.010).

Record type: Article

Abstract

It is well known that aspirin consumption temporarily reduces overall otoacoustic emission (OAE) amplitude in humans. However, little is known about changes in the separate components of distortion product otoacoustic emissions (DPOAE), which may be distinguished by examining phase gradients. The effects of aspirin on the phase gradient of the DPOAE 2F1–F2 obtained with fixed frequency ratio sweeps were studied longitudinally in a group of twelve subjects in whom a temporary hearing loss was induced by aspirin consumption. DPOAE were recorded daily for two days pre-aspirin consumption, during the three days of aspirin consumption and two days afterwards. DP-grams were recorded over a restricted frequency range centered on 2, 3, 4 and 6 kHz with the following stimulus levels: L1/L2 of 60/50–80/70 in 10-dB steps.
The effects of aspirin on the phase gradients varied between the subjects and across frequency: the general trend was that the phase gradient became steeper across successive sessions for the higher frequencies, while no significant effect was found at the lower frequencies.
These results suggest that aspirin may have more persistent effects on cochlear function than are disclosed by measurements of hearing threshold level or DPOAE amplitude. Particularly, DPOAE phase gradient appears to be increased by aspirin consumption and has not recovered two days after cessation of aspirin intake, despite almost complete recovery of DPOAE amplitude and hearing threshold levels. These findings may suggest differential effects on the distortion and reflection mechanisms considered to underlie DPOAE generation.

This record has no associated files available for download.

More information

Published date: 2005
Keywords: distortion product otoacoustic emissions, aspirin, phase gradient
Organisations: Human Sciences Group

Identifiers

Local EPrints ID: 28271
URI: http://eprints.soton.ac.uk/id/eprint/28271
ISSN: 0378-5955
PURE UUID: 3a76401b-522e-49ff-b51a-7278658338d5

Catalogue record

Date deposited: 02 May 2006
Last modified: 15 Mar 2024 07:23

Export record

Altmetrics

Contributors

Author: M. Parazzini
Author: A.J. Hall
Author: M.E. Lutman
Author: S. Kapadia

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×